Godfraind, T. , Kaba, A.: The role of calcium in the action of drugs on vascular smooth muscle. Arch. Int. Pharmacodyn., 96: 35-49, 1972 (Suppl).
2.
Van Nueten, J.M., Janssen, P.A.J.: Comparative study of the effects of flunarizine anc cinnarizine on smooth muscles and cardiac tissues. Arch. Int. Pharmacodyn., 204: 37-55, 1973.
3.
Staessen, A.J. : Treatment of circulatory disturbances with flunarizine and cinnarizine. Vasa, 6: 59-71, 1977.
4.
Joos, F.: Effect of cinnarizine in the treatment of stabilised intermittent claudication . Folio St. Jan, 2: 176-178, 1968.
5.
Simoes Neto, E.: Clinical evaluation of the use of cinnarizine in patients with peripheral vascular disorders. A Folha Medica , 63: 137-146, 1971.
6.
Adriaensen, H.: The treatment of intermittent claudication. A randomized double-blind trial of cinnarizine (Stugeron). Clin. Trials J., 6: 191-193, 1969.
7.
Alexander, K. : Die periphere Kreislaufwirkung von Cinnarizin bei funktionellen Durchblutungsstörungen. Med. Welt., 21: 2132-2134, 1970.
8.
Schuermans, V. , Boermans, A., Geivers, H., et al.: Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle, capacity, and vascular tone . Drug. Res., 21: 1541-1543, 1971 .
9.
Verhaegen, H. , Roels, V., Adriaensen, H., et al.: The arteriolar effects of cinnarizine and flunarizine. Angiology, 25: 261-278, 1974.
10.
Brugmans, J. , Jageneau, A., Adriaensen, H.: Behandlung von peripheren Durchblutungsstörungen der unteren Extremitäten mit Flunarizin und Papaverin. Med. Welt., 28: 1056-1062, 1977.
11.
Schetz, J., Bostoen, H., Clement, D. et al.: Flunarizine in chronic obstructive peripheral arterial disease: A placebo-controlled, double-blind, randomized multicentre trial. Curr. Ther. Res., 23: 121-130, 1978.
12.
Barraine, R. , Efthymiou, T.P., Marcantoni, J.-P.: Action du 1035 MD dans les manifestations vasculaires périphériques. Presse Med., 78: 2389-2390, 1970.
13.
Pfeffer, G. : Cinnarizintherapie bei peripheren Durchblutungsstörungen. Ärztl. Praxis, 22: 4939-4941, 1970 .
14.
Aussems, J. , Muls, M.: Evaluation of the therapeutic efficacy of cinnarizine (Stugeron) in the treatment of crural ulcers. A double-blind study . Clin. Trials J., 7: 273-276, 1970.
15.
Mund-Hoym, W.D.: Erfahrungen in der Behandlung des Ulcus cruris mit Stutgeron. Med. Welt, 27: 1251-1254, 1976.
16.
Jacobs, A.: Le traitement de l'ulcus cruris à la cinnarizine. Ars Medici , 23: 799-802, 1968.
17.
Roekaerts, F., Morias, J., Platteau, K., et al.: The efficacy of flunarizine in venous insufficiency. A double-blind placebo-controlled study. In press.
18.
Oosterveld, W.J.: Pilot evaluation of flunarizine (R 14950) in vertigo—a double-blind trial. Can. J. Otolaryngol. , 3: 284-290, 1974.
19.
Amery, W.K. , Oosterveld, W.J.: An evaluation of cinnarizine in aged patients with vertiginous complaints. A multicentre study. Acta Ther ., 1: 39-48, 1975.
20.
Horn, R.: The influence of cinnarizine on the capacity for concentration. A comparative double-blind study. Pharmakopsychiat., 5: 249-254, 1972.
21.
Bernard, A. , Goffart, J.M.: A double-blind cross-over clinical evaluation of cinnarizine. Clin. Trials J., 5: 945-948, 1968.
22.
Di Perri, T. , Forconi, S., Guerrini, M., et al.: Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease. Proc. R. Soc. Med., 70: 25-28, 1977 (Suppl. 8).
23.
De Clerck, F., De Cree, J., Brugmans, J., et al.: Reduction by flunarizine of the increase of blood viscosity after ischemic forearm occlusion. Arch. Int. Pharmacodyn., 230: 321-323, 1977.
24.
Emanuel, M.D. , Will, J.A.: Cinnarizine in the treatment of peripheral vascular disease: Mechansims related to its clinical action. Proc. R. Soc. Med., 70: 7-12, 1977 (Suppl. 8).
25.
Godfraind, T.: Isoprenaline relaxation in vascular smooth muscle of aged rats. Effect of flunarizine. Arch. Int. Pharmacodyn. , 230: 331, 1977.